# US 2026/0098079 A1 · Method for preparing high-purity and high-stability protein

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0098079 A1
- Document ID: US20260098079A1
- Status: Published application
- Kind: A1
- Application number: 19/112,951
- Filed: 2023-08-28
- Published: 2026-04-09
- Earliest claimed: 2022-10-24
- Assignees: Tonghua Anrate Biopharmaceutical Co., Ltd
- Applicants: Tonghua Anrate Biopharmaceutical Co., Ltd
- Inventors: Wei XIANG; Zhilei YUE; Wenwen DONG; Tingchen GUAN
- Web page: https://patentgrep.com/patent/US20260098079A1

## CPC

- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- C07K 14/765: Serum albumin, e.g. HSA
- C07K 14/76: Albumins
- C07K 1/18: Ion-exchange chromatography
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides a method for obtaining high-purity and high-stability recombinant human albumin, wherein medium-long-chain fatty acid ligands are added and proteins of charge heterogeneity are removed through anion and/or cation chromatography. An inventiveness of the present invention is that the mixed solution contains a fatty acid mixture and poloxamer, and the molar ratio of oleic acid, myristic acid, sodium palmitate, sodium stearate to recombinant human albumin is 0.3:0.3:0.3:0.5:1. Sequential use of ion exchange chromatography can effectively remove truncated albumins, mismatched or modified albumins from recombinant albumins, to remove albumins of charge heterogeneity and modified albumins, to obtain high-purity and high-stability human albumin.

## Claims

### Claim 1

A method for preparing high-purity and high-stability protein, comprising the following steps:
step A: using a 10 KDa membrane to replace a buffer solution of a recombinant human albumin sample collected from a previous purification, with an equilibrium solution system of 80 mM PB of pH 7.5 to obtain a sample collection solution, wherein a mixed solution is added into the sample collection solution, and the mixed solution contains a mixture of fatty acids and poloxamer, and a molar ratio of oleic acid, myristic acid, sodium palmitate, sodium stearate to recombinant human albumin is 0.3:0.3:0.3:0.5:1, and a weight ratio of the poloxamer to the recombinant human albumin is 10-500 micrograms of the poloxamer per gram of the recombinant human albumin, and the poloxamer is used to promote a dissolution of the fatty acids; and
after sample loading, washing an anion exchange chromatography column, which has a column height of 380 mm, with purified water to neutral, and using an eluent system of a 50 mM PB pH 6.5 to elute an adsorbate in the chromatography column to collect a recombinant human albumin component; and
step B: using a 40 mM HAc-NaOH equilibration liquid system to equilibrate a cation exchange chromatography column to collect the recombinant human albumin component, and using a 10 KDa flat sheet membrane to perform desalting and liquid replacement to the collected recombinant human albumin component with a cation exchange chromatography equilibrium liquid, and performing sample loading and chromatography separation to collect the recombinant human albumin component.

### Claim 2 (depends on 1)

The method for preparing high-purity and high-stability protein according to claim 1, comprising the following steps:
step C: using a 30 KDa membrane to replace the buffer solution of the recombinant human albumin sample, which is collected from the previous purification, with an equilibrium solution system of 40 mM HAc-NaOH, and using an equilibrium solution to equilibrate the cation exchange chromatography column, and adding the mixed solution into the sample, the mixed solution contains the mixture of fatty acids and poloxamer; and the molar ratio of oleic acid, myristic acid, sodium palmitate, sodium stearate to the recombinant human albumin is 0.3:0.3:0.3:0.5:1, and performing sample loading and chromatography separation to collect the recombinant human albumin component;
step D: using a 10 KDa membrane to replace the recombinant human albumin component, which is collected in above step C, with the equilibrium solution system of step A, and using the equilibrium solution of step A to equilibrate the anion exchange chromatography column, and using the same method of step A to perform sample loading and purification to collect the recombinant human albumin component.

### Claim 3 (depends on 1)

The method for preparing high-purity and high-stability protein according to claim 1, wherein after step B and/or step D, further comprises the following operations: using a 100 KDa and/or 30 KDa and/or 10 KDa membrane to intercept macromolecular aggregates and remove small molecular substances after the chromatography is finally completed, and performing replacement and concentrating to obtain a recombinant human albumin stock solution with a concentration greater than 20%.

### Claim 4 (depends on 1)

The method for preparing high-purity and high-stability protein according to claim 1, wherein the anion exchange chromatography is purified by forward elution, wherein a pH of the equilibrium solution and the eluent are configured to be between 6.0 and 9.5, and in the method of the present invention, a conductivity in the condition of the anion exchange chromatography is not higher than 20 ms/cm; or the anion exchange chromatography is purified by reverse elution, wherein a pH of the equilibrium solution is configured to be between 4.0 and 6.0, and an equilibrium conductance in the condition of the anion exchange chromatography is not higher than 10 ms/cm.

### Claim 5 (depends on 1)

The method for preparing high-purity and high-stability protein according to claim 1, wherein a pH of the equilibrium solution in a condition of the cation exchange chromatography is configured to be between 4.0 and 6.5, and a conductivity in the condition the cation exchange chromatography is not higher than 10 ms/cm.

### Claim 6 (depends on 1)

The method for preparing high-purity and high-stability protein according to claim 1, wherein the recombinant human albumin sample, which collected from the previous purification, is a human albumin expressed by large-scale production of genetically recombinant microorganisms.
